Literature DB >> 3320027

Heterozygous beta thalassaemia with intermediate clinical severity in 9 members of two unrelated families showing vertical transmission.

M B Agarwal.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3320027

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN： 0004-5772


× No keyword cloud information.
  24 in total

1.  LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer.

Authors:  A Giro-Perafita; L Luo; A Khodadadi-Jamayran; M Thompson; B Akgol Oksuz; A Tsirigos; B D Dynlacht; I Sánchez; F J Esteva
Journal:  NPJ Breast Cancer       Date:  2020-01-06

Review 2.  Design and analysis of CRISPR-Cas experiments.

Authors:  Ruth E Hanna; John G Doench
Journal:  Nat Biotechnol       Date:  2020-04-13       Impact factor: 54.908

3.  GAB2 and GAB3 are expressed in a tumor stage-, grade- and histotype-dependent manner and are associated with shorter progression-free survival in ovarian cancer.

Authors:  Caglar Berkel; Ercan Cacan
Journal:  J Cell Commun Signal       Date:  2020-09-04       Impact factor: 5.782

4.  Predicting breast cancer drug response using a multiple-layer cell line drug response network model.

Authors:  Pingzhao Hu; Ted M Lakowski; Shujun Huang
Journal:  BMC Cancer       Date:  2021-05-31       Impact factor: 4.430

5.  KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth.

Authors:  Susanna Raho; Loredana Capobianco; Rocco Malivindi; Angelo Vozza; Carmela Piazzolla; Francesco De Leonardis; Ruggiero Gorgoglione; Pasquale Scarcia; Francesca Pezzuto; Gennaro Agrimi; Simona N Barile; Isabella Pisano; Stephan J Reshkin; Maria R Greco; Rosa A Cardone; Vittoria Rago; Yuan Li; Carlo M T Marobbio; Wolfgang Sommergruber; Christopher L Riley; Francesco M Lasorsa; Edward Mills; Maria C Vegliante; Giuseppe E De Benedetto; Deborah Fratantonio; Luigi Palmieri; Vincenza Dolce; Giuseppe Fiermonte
Journal:  Nat Metab       Date:  2020-11-23

Review 6.  Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.

Authors:  Ferdinandos Skoulidis; John V Heymach
Journal:  Nat Rev Cancer       Date:  2019-08-12       Impact factor: 60.716

7.  Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling.

Authors:  Steven M Corsello; Rohith T Nagari; Ryan D Spangler; Jordan Rossen; Mustafa Kocak; Jordan G Bryan; Ranad Humeidi; David Peck; Xiaoyun Wu; Andrew A Tang; Vickie M Wang; Samantha A Bender; Evan Lemire; Rajiv Narayan; Philip Montgomery; Uri Ben-David; Colin W Garvie; Yejia Chen; Matthew G Rees; Nicholas J Lyons; James M McFarland; Bang T Wong; Li Wang; Nancy Dumont; Patrick J O'Hearn; Eric Stefan; John G Doench; Caitlin N Harrington; Heidi Greulich; Matthew Meyerson; Francisca Vazquez; Aravind Subramanian; Jennifer A Roth; Joshua A Bittker; Jesse S Boehm; Christopher C Mader; Aviad Tsherniak; Todd R Golub
Journal:  Nat Cancer       Date:  2020-01-20

8.  ZNF37A promotes tumor metastasis through transcriptional control of THSD4/TGF-β axis in colorectal cancer.

Authors:  Jiayang Liu; Zhao Huang; Hai-Ning Chen; Siyuan Qin; Yan Chen; Jingwen Jiang; Zhe Zhang; Maochao Luo; Qin Ye; Na Xie; Zong-Guang Zhou; Yuquan Wei; Ke Xie; Canhua Huang
Journal:  Oncogene       Date:  2021-04-19       Impact factor: 9.867

9.  Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry.

Authors:  Amit Kulkarni; Tiago Ferreira; Clemens Bretscher; Annabel Grewenig; Nazim El-Andaloussi; Serena Bonifati; Tiina Marttila; Valérie Palissot; Jubayer A Hossain; Francisco Azuaje; Hrvoje Miletic; Lars A R Ystaas; Anna Golebiewska; Simone P Niclou; Ralf Roeth; Beate Niesler; Amélie Weiss; Laurent Brino; Antonio Marchini
Journal:  Nat Commun       Date:  2021-06-22       Impact factor: 14.919

10.  Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways.

Authors:  Zhen Xiang; Zhijun Zhou; Shuzheng Song; Jun Li; Jun Ji; Ranlin Yan; Jiexuan Wang; Wei Cai; Wenjun Hu; Lu Zang; Zhenggang Zhu; Zhen Zhang; Min Li; Yingyan Yu
Journal:  Oncogene       Date:  2021-06-26       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.